RLX Technology (RLX) Q2 2026 earnings review
Margins Surge, But Cash Flow and Bottom Line Tell a Troubling Story
RLX reported a heavily mixed Q2. While revenue grew 14.8% YoY to RMB 1.01B, this represents a severe 36% sequential deceleration from Q1's tax-driven pull-forward. Management lauded 'solid results,' but a look under the hood contradicts the bullishness: Non-GAAP Net Income actually dropped 18% YoY as operating expenses spiked, and Operating Cash Flow turned negative for the second consecutive quarter. The bright spot was Gross Margin, which hit a stellar 35.4%. RLX is doubling down on Europe via a 51% M&A stake, but the core business is facing undeniable working capital and expense pressures.
🐂 Bull Case
Gross margin expanded to 35.4%, a massive leap from 27.5% a year ago, proving supply chain optimization and international mix are structurally improving product economics.
The July 2026 acquisition of a 51% stake in a major Western European distributor locks in a crucial B2B digital route-to-market for future scaling.
🐻 Bear Case
Despite 48% YoY Gross Profit growth, Non-GAAP Net Income shrank 18% YoY. Operating expenses are rising far faster than the bottom line can absorb.
Operating cash flow was negative RMB 63.2M, marking the second straight quarter of cash bleed, driven by rising receivables and related-party balances.
⚖️ Verdict: 🔴
Bearish. The spectacular gross margin expansion is completely negated by negative cash flows, surging selling expenses, and an 18% YoY drop in adjusted net income. The normalization after Q1's artificial revenue spike reveals a pressured operational core.
Key Themes
Operating Cash Flow Reversing into the Red
A massive contradiction to the 'stable' narrative: Operating Cash Flow was negative RMB 63.2M. This follows a negative RMB 68.8M print in 26Q1. The cash burn is moving in the exact opposite direction of reported GAAP Net Income (RMB 222.0M). The balance sheet shows Accounts Receivable up to RMB 333M and 'Amounts due from related parties' up to RMB 483M. Working capital is locking up cash.
Profitability Squeeze: Rising Expenses Crush Bottom Line
Reversing. Despite Gross Profit jumping 47.8% YoY, Non-GAAP Net Income fell 18.0% (to RMB 238.8M from RMB 291.2M). This was heavily driven by a 46% YoY explosion in Selling Expenses (RMB 123.7M) tied to salary, welfare, branding, and amortization from prior M&A. The company is failing to demonstrate operating leverage on its international expansion.
Macro Impact: Export Regulation Hangover
Decelerating. Revenue plummeted 36% sequentially (RMB 1.58B to RMB 1.01B). Management admitted Q1 was artificially inflated due to 'strategic inventory positioning' by partners ahead of the April 2026 cancellation of the Chinese export tax rebate. Now that the front-loading is over, the underlying run-rate of the business appears much weaker than Q1 suggested. International business share also dropped sequentially to 68.5% from 72.3%.
Gross Margin Acceleration
Accelerating. The undisputed bright spot of the quarter was gross margin hitting 35.4%, up dramatically from 27.5% a year ago and 31.8% in Q1. Management attributes this to a favorable international revenue mix and ongoing supply chain optimization, suggesting unit economics of the core hardware are structurally sound.
European B2B Consolidation
Stable. RLX's 'dual-engine' M&A strategy took a major step with the July 2026 acquisition of a 51% stake in a Western European distributor. By absorbing a multi-channel logistics network and a proprietary B2B digital ordering platform, RLX is buying local market access rather than attempting to build it organically from scratch.
Product Innovation: Modern Oral Nicotine Pouches
Accelerating. RLX is officially pivoting into a broader 'smoke-free' portfolio. Management highlighted the scaling of newly launched modern oral nicotine pouches to capture smokeless categories beyond e-vapor. This product diversification is critical to hedge against the volatile regulatory frameworks surrounding vapes globally.
Other KPIs
Decelerating. Total cash, deposits, and short-term investments fell from RMB 14.53 billion in March 2026. While the balance sheet remains a fortress, the sequential drop reflects the combination of negative operating cash flow, continued strategic investments, and working capital needs.
Accelerating YoY. Up an impressive 234.7% from just RMB 39.0M in 25Q2, though this is heavily skewed by a sharp drop in share-based compensation expenses compared to the prior year period. Adjusting for SBC, Non-GAAP operating income only grew 28.8%.
Guidance
Accelerating. The financials of the newly acquired Western European distributor will be fully consolidated starting in Q3 2026. This will immediately boost top-line revenue but will likely put further pressure on operating expenses and short-term net margins due to integration costs.
Key Questions
Disconnect Between Net Income and OCF
You reported positive GAAP net income of RMB 222 million, yet operating cash flow was negative RMB 63 million. Given the spike in 'Amounts due from related parties,' are partners struggling to pay, or are you intentionally extending credit terms to support international growth?
Expense Deleverage
Selling expenses outpaced revenue growth dramatically this quarter, leading to an 18% YoY decline in Non-GAAP Net Income. At what revenue scale do you expect these international and M&A-related investments to show operating leverage?
True Organic Growth Rate
Given the 36% sequential drop in revenue due to the Q1 export tax pre-stocking anomaly, what is the actual, normalized organic growth rate of the international business heading into the second half of 2026?